- Home
- PFE vs SNY Comparison
PFE vs SNY Comparison
Compare PFE & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFE
- SNY
- Stock Information
- Founded
- PFE 1849
- SNY 1994
- Country
- PFE United States
- SNY France
- Employees
- PFE N/A
- SNY N/A
- Industry
- PFE Biotechnology: Pharmaceutical Preparations
- SNY Biotechnology: Pharmaceutical Preparations
- Sector
- PFE Health Care
- SNY Health Care
- Exchange
- PFE Nasdaq
- SNY Nasdaq
- Market Cap
- PFE N/A
- SNY 144.8B
- IPO Year
- PFE N/A
- SNY N/A
- Fundamental
- Price
- PFE $25.70
- SNY $55.47
- Analyst Decision
- PFE Buy
- SNY Buy
- Analyst Count
- PFE 14
- SNY 2
- Target Price
- PFE $31.92
- SNY $62.50
- AVG Volume (30 Days)
- PFE 56.3M
- SNY 3.0M
- Earning Date
- PFE 04-29-2025
- SNY 04-24-2025
- Dividend Yield
- PFE 6.73%
- SNY 3.96%
- EPS Growth
- PFE 284.33
- SNY 2.94
- EPS
- PFE 1.41
- SNY 4.60
- Revenue
- PFE $63,627,000,000.00
- SNY $45,849,466,833.00
- Revenue This Year
- PFE $0.06
- SNY $6.91
- Revenue Next Year
- PFE $0.13
- SNY $6.60
- P/E Ratio
- PFE $18.10
- SNY $12.06
- Revenue Growth
- PFE 6.84
- SNY 7.73
- 52 Week Low
- PFE $24.48
- SNY $45.22
- 52 Week High
- PFE $31.54
- SNY $60.12
- Technical
- Relative Strength Index (RSI)
- PFE 48.35
- SNY 50.38
- Support Level
- PFE $25.89
- SNY $55.78
- Resistance Level
- PFE $26.52
- SNY $59.17
- Average True Range (ATR)
- PFE 0.47
- SNY 0.78
- MACD
- PFE 0.01
- SNY -0.43
- Stochastic Oscillator
- PFE 30.75
- SNY 20.12
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.